VitaNova Life Sciences Corp (VNOV) stock
VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$4.50+0.50 (+12.50%)
Close on Oct 19, 2026Market cap $37.52MP/E –Yield –
VitaNova Life Sciences operating margin
Operating margin is operating income as a percentage of revenue.
VitaNova Life Sciences's operating margin for the twelve months ending Jul 31, 2026 was -2.7%. For fiscal 2026 it was 0.1%, against 45.4% the year before. The highest annual figure on record is 45.4% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | 0.1% | −45.3 |
| FY2025 | Apr 30, 2025 | 45.4% | +9.4 |
| FY2024 | Apr 30, 2024 | 36.0% | +99.8 |
| FY2023 | Apr 30, 2023 | -63.8% | −52.6 |
| FY2022 | Apr 30, 2022 | -11.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | -38.0% | −6.8 |
| Q4 FY2026CQ1 2026 | Apr 30, 2026 | -6.2% | −61.6 |
| Q3 FY2026CQ4 2025 | Jan 31, 2026 | 6.6% | −28.7 |
| Q2 FY2026CQ3 2025 | Oct 31, 2025 | 23.2% | +1.8 |
| Q1 FY2026CQ2 2025 | Jul 31, 2025 | -31.2% | +10.6 |
| Q4 FY2025CQ1 2025 | Apr 30, 2025 | 55.4% | +12.7 |
| Q3 FY2025CQ4 2024 | Jan 31, 2025 | 35.3% | +12.5 |
| Q2 FY2025CQ3 2024 | Oct 31, 2024 | 21.4% | +7.2 |
| Q1 FY2025CQ2 2024 | Jul 31, 2024 | -41.9% | +24.8 |
| Q4 FY2024CQ1 2024 | Apr 30, 2024 | 42.7% | – |
| Q3 FY2024CQ4 2023 | Jan 31, 2024 | 22.8% | – |
| Q1 FY2023CQ2 2022 | Jul 31, 2022 | 14.2% | – |
| Q2 FY2022CQ3 2021 | Oct 31, 2021 | -66.6% | – |
See a number that looks wrong?